Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 5239

BillFederalHouseIn Committee
Prescription Drug Price Reporting Act
About This Bill
Committee
Latest Action · November 22, 2019
Referred to the Subcommittee on Health.
Congress
116th (2019–2021)
Introduced
November 21, 2019
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Prescription Drug Price Reporting ActThis bill requires that all prescription drug manufacturers submit certain information for every drug marketed in the United States to the Department of Health and Human Services (HHS). Specifically, manufacturers must provide information about cost, pricing, and rebates. Manufacturers are also required to submit any price changes to a prescription drug at least 30 days in advance.HHS must make this information available through a public database that enables consumers to subscribe to price change notifications for different types of prescriptions drugs.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.